Brimarafenib is under clinical development by MapKure and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I drugs for Pancreatic Cancer have a 74% phase transition success ...
Camrelizumab is under clinical development by Jiangsu Hengrui Medicine and currently in Phase II for Pancreatic Cancer.
In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has some history on its ... Read ...
TAG24 NEWS on MSN15m
The tell-tale signs of pancreatic cancer everyone over 50 should knowPancreatic cancer can often be halted, but it's rarely detected in time.The largest gland in the human body produces enzymes and hormones that are vital for digestion and metabolism. However, it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback